-+ 0.00%
-+ 0.00%
-+ 0.00%

Bernstein Maintains Outperform on Insulet, Lowers Price Target to $330

Benzinga·02/19/2026 17:32:28
Listen to the news
Bernstein analyst Lee Hambright maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $380 to $330.